Online Program Home
My Program

CC = Colorado Convention Center   H = Hyatt Regency Denver at Colorado Convention Center
* = applied session       ! = JSM meeting theme

Activity Details

459 ! Wed, 7/31/2019, 8:30 AM - 10:20 AM CC-111
Rethinking Intercurrent Events and Estimators Within the ICH E9(R1) Estimand Framework — Topic Contributed Papers
Biopharmaceutical Section, Biometrics Section, ENAR
Organizer(s): Dong Xi, Novartis
Chair(s): Forrest Williamson, Eli Lilly
8:35 AM A Constructive Critique of the Draft ICH E9 Addendum

Daniel Scharfstein, Johns Hopkins School of Hygiene & Public Health
8:55 AM Estimands in Clinical Trials with Intercurrent Events
Shanthi Sethuraman, Eli Lilly and Company; Yongming Qu, Eli Lilly and Company; Linda Shurzinske, Eli Lilly and Company
9:15 AM Comparison of Assumptions Required for Estimating Different Parameters in the Presence of Intercurrent Events

Michael Rosenblum, Johns Hopkins Bloomberg School of Public Health
9:35 AM Some Thoughts on Recurrent Event Estimands and Estimators
Dong Xi, Novartis; Jiawei Wei, Novartis; Tobias Muetze, Novartis
9:55 AM Discussant: Thomas Permutt, U.S. Food and Drug Administration
10:15 AM Floor Discussion